UA87158C2 - Тестостероновый гель, содержащий пропиленгликоль в качестве усилителя проникающей способности - Google Patents

Тестостероновый гель, содержащий пропиленгликоль в качестве усилителя проникающей способности

Info

Publication number
UA87158C2
UA87158C2 UAA200703868A UAA200703868A UA87158C2 UA 87158 C2 UA87158 C2 UA 87158C2 UA A200703868 A UAA200703868 A UA A200703868A UA A200703868 A UAA200703868 A UA A200703868A UA 87158 C2 UA87158 C2 UA 87158C2
Authority
UA
Ukraine
Prior art keywords
propylene glycol
containing propylene
penetration enhancer
gels containing
testosterone gels
Prior art date
Application number
UAA200703868A
Other languages
English (en)
Ukrainian (uk)
Inventor
Домінік Салєн-Друен
Original Assignee
Лаборатуар Безен Ентернасьональ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лаборатуар Безен Ентернасьональ filed Critical Лаборатуар Безен Ентернасьональ
Publication of UA87158C2 publication Critical patent/UA87158C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Данное изобретение относится к тестостеронсодержащим фармацевтическим композициям в форме геля, содержащего пропиленгликоль, в качестве агента, повышающего проницаемость.
UAA200703868A 2004-09-09 2005-09-07 Тестостероновый гель, содержащий пропиленгликоль в качестве усилителя проникающей способности UA87158C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04292170A EP1634583A1 (en) 2004-09-09 2004-09-09 Testosterone gels comprising propylene glycol as penetration enhancer

Publications (1)

Publication Number Publication Date
UA87158C2 true UA87158C2 (ru) 2009-06-25

Family

ID=34931375

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200703868A UA87158C2 (ru) 2004-09-09 2005-09-07 Тестостероновый гель, содержащий пропиленгликоль в качестве усилителя проникающей способности

Country Status (12)

Country Link
US (1) US20080038220A1 (ru)
EP (3) EP1634583A1 (ru)
KR (1) KR20070099532A (ru)
CN (1) CN101018542B (ru)
AU (1) AU2005281809A1 (ru)
CA (1) CA2578225C (ru)
DK (1) DK1786398T3 (ru)
ES (1) ES2548723T3 (ru)
NO (1) NO341780B1 (ru)
UA (1) UA87158C2 (ru)
WO (1) WO2006027278A1 (ru)
ZA (1) ZA200701864B (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
KR20050045946A (ko) 2002-06-25 2005-05-17 애크럭스 디디에스 피티와이 리미티드 비정질 약학적 조성물을 이용한 경피전달속도의 제어
EP1868590A4 (en) * 2005-04-13 2012-08-29 Unimed Pharmaceuticals Inc PROCESS FOR INCREASING TESTOSTERONE AND CORRESPONDING STEROID CONCENTRATIONS IN WOMEN
WO2006125642A1 (en) * 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
ZA200711040B (en) 2005-06-03 2009-04-29 Acrux Dds Pty Ltd Method and composition for transdermal drug delivery
ES3012497T3 (en) 2005-10-12 2025-04-09 Besins Healthcare Lu Sarl Improved testosterone gel and method of use
CA2646667C (en) 2006-04-21 2014-03-11 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
NZ578883A (en) 2007-01-11 2012-05-25 Acrux Dds Pty Ltd Open top applicator for spreading liquid on skin
US20090285893A1 (en) * 2008-05-19 2009-11-19 The Procter & Gamble Company Treatment of heart failure in women
EP2147674A1 (en) * 2008-07-24 2010-01-27 Besins Healthcare Transdermal pharmaceutical compositions comprising danazol
KR20110090892A (ko) * 2008-10-31 2011-08-10 모베르그 데르마 아베 두 개 이상의 침투 증강제의 조합으로 구성되는 국소 조성물
PL3202420T3 (pl) * 2008-12-11 2020-07-13 Besins Healthcare Luxembourg Sarl Transdermalne kompozycje farmaceutyczne zawierające SERM
WO2011046522A2 (fr) * 2009-10-16 2011-04-21 Rached Smida Nouvelles applications de la testosterone libre reconstituee
US10080760B2 (en) 2009-10-27 2018-09-25 Besins Healthcare Luxembourg Sarl Transdermal pharmaceutical compositions comprising active agents
JO3755B1 (ar) * 2011-01-26 2021-01-31 Ferring Bv تركيبات تستوستيرون
USD750788S1 (en) 2013-11-26 2016-03-01 Acrux Dds Pty Ltd Topical spreading applicator
USD749225S1 (en) 2013-11-26 2016-02-09 Acrux Dds Pty Ltd Topical spreading applicator
WO2015128876A2 (en) * 2014-02-25 2015-09-03 Intas Pharmaceuticals Limited Stable transdermal testosterone gel

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5238933A (en) * 1991-10-28 1993-08-24 Sri International Skin permeation enhancer compositions
US5837289A (en) * 1996-07-23 1998-11-17 Grasela; John C. Transdermal delivery of medications using a combination of penetration enhancers
US5760096A (en) * 1996-10-18 1998-06-02 Thornfeldt; Carl R. Potent penetration enhancers
US5968919A (en) * 1997-10-16 1999-10-19 Macrochem Corporation Hormone replacement therapy drug formulations for topical application to the skin
US6319913B1 (en) * 1997-11-10 2001-11-20 Cellegy Pharmaceuticals, Inc. Penetration enhancing and irritation reducing systems
US6582724B2 (en) * 1999-12-16 2003-06-24 Dermatrends, Inc. Dual enhancer composition for topical and transdermal drug delivery
US20030139384A1 (en) * 2000-08-30 2003-07-24 Dudley Robert E. Method for treating erectile dysfunction and increasing libido in men
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
WO2002017927A1 (en) * 2000-08-30 2002-03-07 Unimed Pharmaceuticals, Inc. Method for treating erectile dysfunction and increasing libido in men
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
DK1347764T3 (da) * 2000-12-22 2007-07-23 August Wolff Gmbh & Co Kg Arzn Gelpræparat på alkoholisk basis til behandling af hypogonadisme ved transskrotal applikation
US20040072810A1 (en) * 2001-11-07 2004-04-15 Besins International Belgique Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
DK1317921T3 (da) * 2001-12-07 2009-12-21 Besins Mfg Belgium Farmaceutisk sammensætning i form af en gel eller oplösning med dihydrotestosteron, fremgangsmåde til fremstilling og anvendelser heraf
MY139721A (en) * 2002-04-19 2009-10-30 Cpex Pharmaceuticals Inc Pharmaceutical composition
US20050020552A1 (en) * 2003-07-16 2005-01-27 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
ES3012497T3 (en) * 2005-10-12 2025-04-09 Besins Healthcare Lu Sarl Improved testosterone gel and method of use

Also Published As

Publication number Publication date
WO2006027278A1 (en) 2006-03-16
EP1786398B1 (en) 2015-08-12
ES2548723T3 (es) 2015-10-20
NO20071823L (no) 2007-06-11
ZA200701864B (en) 2008-05-28
CN101018542A (zh) 2007-08-15
EP2957279A1 (en) 2015-12-23
EP1634583A1 (en) 2006-03-15
US20080038220A1 (en) 2008-02-14
CA2578225C (en) 2014-06-03
DK1786398T3 (en) 2015-11-23
NO341780B1 (no) 2018-01-22
EP2957279B1 (en) 2022-11-02
EP1786398A1 (en) 2007-05-23
AU2005281809A1 (en) 2006-03-16
CA2578225A1 (en) 2006-03-16
KR20070099532A (ko) 2007-10-09
CN101018542B (zh) 2020-05-19

Similar Documents

Publication Publication Date Title
UA87158C2 (ru) Тестостероновый гель, содержащий пропиленгликоль в качестве усилителя проникающей способности
UA86591C2 (ru) Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе
SG152292A1 (en) Pharmaceutical compositions
MY150102A (en) Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
PT1411908E (pt) Tratamento de infeccoes da unha com no
TNSN07322A1 (en) Pyrimidine derivatives for treatment of hyperproliferative disorders
UA100228C2 (ru) Фармацевтическая композиция, содержащая тетрагидрофолиевую кислоту
UA94417C2 (ru) Замещенные 7-азаиндазолы, композиция, которая их содержит, и применение
TW200639173A (en) Substituted pyrazolopyridines, compositions containing same, manufacturing process therefor and use thereof
PH12012501199A1 (en) Chalcones as enhancer of antimicrobial agents
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
TW200510344A (en) Aryl-heteroaromatic products, compositions comprising them and use
MX2007006539A (es) Sistema para la absorcion percutanea mejorada de los agentes beneficiadores de la piel.
TW200738659A (en) Novel compounds
UA87335C2 (en) Gel composition of 4-hydroxytamoxifen
EP1594509A4 (en) COMPOSITIONS AND METHODS FOR TREATMENT OF IRRITABLE COLON SYNDROME AND NON ULCEREUS DYSPEPSIS
ATE535251T1 (de) Stabile wässrige g-csf-haltige zusammensetzungen
NO20082848L (no) Farmasoytisk formulering for behandling av osteoartritt inneholdende klodronsyre og hyaluronsyre
MXPA05008902A (es) Soluciones de drogas en mentol.
SG165404A1 (en) Fulvestrant formulation
MX2007002814A (es) Geles de testosterona comprendiendo propilenglicol como mejorador de penetracion.
TW200621269A (en) Polyethylene glycol-peptide copper complexes and compositions and methods related thereto
TW200640858A (en) Substituted pyrroles, compositions containing them, method of manufacture and use
MXPA05006530A (es) Derivados de 1-n-fenilamino-1h-imidazola como inhibidores aromatasa.
WO2004054983A3 (en) 1-n-phenylamino-1h-imidazole derivatives as aromatase inhibitors